Balancing Inflammatory, Lipid, and Xenobiotic Signaling Pathways by VSL#3, a Biotherapeutic Agent, in the Treatment of Inflammatory Bowel Disease

C. Reiff, M. Delday, G. Rucklidge, M. Reid, G. Duncan, S. Wohlgemuth, G. Hoermannsperger, G. Loh, M. Blaut, E. Collie-Duguid, D. Haller, D. Kelly

Research output: Contribution to journalArticlepeer-review

58 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Balancing Inflammatory, Lipid, and Xenobiotic Signaling Pathways by VSL#3, a Biotherapeutic Agent, in the Treatment of Inflammatory Bowel Disease'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Medicine and Dentistry